Chengdu FenDi Pharmaceutical Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Chengdu FenDi Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of FD-001 in Recurrent /Refractory (R/R)AML/NHL/MM/MDS (NCT06731699) | Chengdu FenDi Pharmaceutical Co., Ltd. | 2024-03-11 |
Track Chengdu FenDi Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.